Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OPRA | CNXC |
|---|---|---|
| Price | $17.71 | $25.87 |
| Change today | ▲ 0.06% | ▲ 3.85% |
| Market cap | $1.57B | $1.58B |
| Return, 3 months | -10.0% | +15.1% |
| Return, year to date | +31.1% | -35.3% |
| Return, 1 year | +3.5% | -43.0% |
| P/E (TTM) | 12.8 | -0.7 |
| P/B | 1.6 | 0.9 |
| P/E percentile vs own 5y | – | 17th |
| Dividend yield | 6.78% | 5.57% |
| Revenue growth (YoY, latest qtr) | +24.6% | – |
| Net profit growth (YoY) | +75.7% | – |
| Gross margin | 62.1% | – |
| Operating margin | 16.4% | – |
| Net margin | 15.5% | – |
| Return on equity | – | – |
| Analyst target vs. price | +51.5% | +34.0% |
| Analyst buy share | 100% | 67% |
| RSI (14) | 41 | 45 |
| 30-day volatility | 22.5% | 78.5% |
| Max drawdown, 1 year | -41.3% | -61.1% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
